The global market for coronary stents is set to experience robust growth, with projections indicating a rise from US$9.6 billion in 2023 to US$12.6 billion by 2030, achieving a compound annual growth rate (CAGR) of 4% over the forecast period. This growth is driven by advancements in stent materials, increasing prevalence of cardiovascular diseases (CVDs), and the adoption of minimally invasive procedures.
This product will be delivered within 1-3 business days.
Key Market Drivers
Several factors propel the coronary stents market forward:
- Technological Advancements: Innovations in stent materials, such as biodegradable polymers and cobalt chromium, enhance biocompatibility and mechanical properties, reducing long-term complications.
- Rising Incidence of CVDs: The global increase in cardiovascular diseases necessitates effective interventional therapies like coronary stents, boosting market demand.
- Preference for Minimally Invasive Procedures: Growing patient and physician preference for minimally invasive treatments over traditional surgeries fuels market expansion.
Market Challenges
Despite growth prospects, the market faces challenges:
- Regulatory Hurdles: Stringent regulatory approvals delay product launches, impacting market agility and innovation.
- Cost Barriers: High procedural costs and limited reimbursement options in certain regions hinder market accessibility.
Emerging Trends and Opportunities
Exciting developments shaping the market include:
- Bioresorbable Stents: Increasing adoption due to their ability to dissolve over time, reducing long-term complications and obviating the need for permanent implants.
- Personalized Treatment Approaches: Tailoring stents to individual patient characteristics enhances treatment efficacy and minimizes adverse effects.
- AI Integration: Utilizing artificial intelligence for precise stent design and deployment improves procedural outcomes, particularly in developed healthcare markets.
Regional Market Leaders
North America leads with the highest market penetration, driven by advanced healthcare infrastructure and a high prevalence of CVDs. Asia Pacific shows rapid growth, fueled by rising healthcare expenditure and awareness of cardiovascular health.The coronary stents market is competitive, with key players focusing on:
- Product Innovation: Emphasis on biodegradable materials and advanced drug-eluting mechanisms.
- Market Expansion: Strategic initiatives to penetrate emerging markets and enhance global footprint.
- Partnerships and Acquisitions: Collaborations to bolster technological capabilities and regulatory compliance.
Market Key Players:
- Medtronic
- Abbott
- Boston Scientific Corporation
- B Braun Melsungen AG
- Terumo Corporation
- MicroPort Scientific Corporation
- Biotronik
- R. Bard, Inc.
- Stentys SA
- Cook Medical
Market Segmentation:
By Product Type:
- Drug-Eluting Stent
- Bare Metal Stent
- Bioresorbable stent
By Raw Material Type:
- Cobalt Chromium
- Stainless Steel
- Platinum Chromium
- Polymer
By End User:
- Hospitals
- Ambulatory Surgical Centres
- Cardiac Catheterization Laboratories
By Geographic Coverage:
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Turkey
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Egypt
- Nigeria
- Rest of the Middle East & Africa
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global Coronary Stents Market Outlook, 2018 - 2030
4. North America Coronary Stents Market Outlook, 2018 - 2030
5. Europe Coronary Stents Market Outlook, 2018 - 2030
6. Asia Pacific Coronary Stents Market Outlook, 2018 - 2030
7. Latin America Coronary Stents Market Outlook, 2018 - 2030
8. Middle East & Africa Coronary Stents Market Outlook, 2018 - 2030
9. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic
- Abbott
- Boston Scientific Corporation
- B Braun Melsungen AG
- Terumo Corporation
- MicroPort Scientific Corporation
- Biotronik
- C. R. Bard, Inc.
- Stentys SA
- Cook Medical
Methodology
LOADING...